Fortify

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the topical application in adults and children aged 12 years and older. It is to be applied in a thick layer to the throat and chest. For enhanced efficacy, the area may be covered with a warm, dry cloth if desired. It is recommended that clothing around the throat and chest be loose to facilitate the release of vapors to the nose and mouth.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage for the medication is up to three times daily, or as directed by a healthcare professional. For children under 12 years of age, it is advised to consult a doctor prior to administration to determine the appropriate dosage and ensure safety.

Contraindications

Use of this product is contraindicated in patients with a history of epilepsy due to the potential for exacerbating seizures. Additionally, it should not be used in individuals with high blood pressure, as it may pose further cardiovascular risks.

The product should not be subjected to heating, microwaving, or exposure to an open flame. It is also contraindicated to add the product to hot water or any container where water is being heated, as this may lead to splattering and result in burns.

Warnings and Precautions

For external use only; this product is not intended for oral ingestion or nasal application. It is important to note that the product is flammable; therefore, it should be kept away from fire or flame to prevent any hazardous incidents.

In the event of accidental ingestion, immediate medical assistance should be sought. Healthcare professionals are advised to contact a Poison Control Center or seek emergency medical help without delay.

Patients should be instructed to discontinue use and consult their healthcare provider if a cough persists for more than one week, recurs, or is accompanied by additional symptoms such as fever, rash, or a persistent headache. A persistent cough may indicate an underlying serious condition that requires further evaluation and management.

Side Effects

Patients using this product may experience various adverse reactions. It is important to note that this product is for external use only and should not be ingested or placed in the nostrils. Additionally, the product is flammable; therefore, it should be kept away from fire or flame.

In clinical practice, patients are advised to stop using the product and consult a healthcare professional if a cough persists for more than one week, recurs, or is accompanied by fever, rash, or a persistent headache. A persistent cough may indicate a serious underlying condition that requires medical evaluation.

Before using this product, patients should seek medical advice if they have a persistent or chronic cough, such as that associated with smoking, asthma, or emphysema, or if their cough is accompanied by excessive phlegm (mucus). These conditions may necessitate a different therapeutic approach.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Fortify (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents and children aged 12 years and older, the recommended application is to rub a thick layer on the throat and chest, up to three times daily or as directed by a healthcare provider.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should not use this product. The potential risks associated with the use of this product during pregnancy or lactation have not been established, and its safety in these populations has not been evaluated. Therefore, healthcare professionals are advised to consider alternative treatments for women who are pregnant or nursing.

Lactation

Lactating mothers are advised against the use of this product while breastfeeding. There is no available data on the excretion of the product in human milk or its effects on breastfed infants. Therefore, caution is warranted, and alternative treatments should be considered for lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage information is not available, healthcare professionals should exercise caution, remain observant for potential overdose symptoms, and implement appropriate management strategies as needed.

Nonclinical Toxicology

If pregnant or breast-feeding, the use of this product is contraindicated due to potential teratogenic effects. No non-teratogenic effects have been specified in the available data. Additionally, there are no details provided regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that this product should not be used by individuals with epilepsy or those who have high blood pressure.

Patients should be instructed to discontinue use and consult a doctor if their cough persists for more than one week, recurs, or is accompanied by symptoms such as fever, rash, or a persistent headache, as these may indicate a serious underlying condition.

When discussing the use of this product, healthcare providers should emphasize that it should not be heated, microwaved, or used near an open flame. Patients should also be cautioned against adding the product to hot water or any container where water is being heated, as this may cause splattering and result in burns.

Additionally, healthcare providers should recommend that patients consult a doctor before using the product if they have a persistent or chronic cough associated with smoking, asthma, or emphysema, or if their cough is accompanied by excessive phlegm (mucus).

Storage and Handling

The product is supplied in a container that should be closed tightly after use. It is recommended to store the product at room temperature, ensuring it is kept away from heat sources. Additionally, recycling of the container is encouraged where possible.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Fortify, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)